Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$691K Sell
1,907
-140
-7% -$47.9K 0.01% 384
2026
Q1
$720K Sell
2,047
-97
-5% -$34.6K 0.01% 367
2025
Q4
$702K Sell
2,144
-321
-13% -$102K 0.01% 370
2025
Q3
$696K Buy
2,465
+184
+8% +$53.4K 0.01% 382
2025
Q2
$637K Sell
2,281
-527
-19% -$149K 0.01% 379
2025
Q1
$875K Buy
2,808
+422
+18% +$125K 0.01% 264
2024
Q4
$622K Sell
2,386
-1,296
-35% -$385K 0.01% 327
2024
Q3
$1.15M Buy
3,682
+1,166
+46% +$381K 0.02% 245
2024
Q2
$715K Buy
2,516
+972
+63% +$286K 0.01% 275
2024
Q1
$439K Sell
1,544
-768
-33% -$225K 0.01% 296
2023
Q4
$621K Sell
2,312
-184
-7% -$50.1K 0.01% 214
2023
Q3
$554K Buy
2,496
+359
+17% +$89.6K 0.01% 235
2023
Q2
$517K Sell
2,137
-439
-17% -$102K 0.01% 224
2023
Q1
$676K Sell
2,576
-102
-4% -$25K 0.01% 231
2022
Q4
$604K Sell
2,678
-202
-7% -$54.1K 0.01% 226
2022
Q3
$701K Buy
2,880
+324
+13% +$78.5K 0.01% 176
2022
Q2
$618K Buy
+2,556
New +$626K 0.01% 175

Other funds holding AMGN

Blue Trust Inc's AMGN Position: Q2 2026 in Review

Blue Trust Inc reduced its Amgen (AMGN) stake by 6.8% in Q2 2026, selling an estimated $47.9K and leaving 1,907 shares worth $691K. The position accounts for 0.01% of the portfolio, ranked #384.

Blue Trust Inc first reported a position in AMGN in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.15M in Q3 2024. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Blue Trust Inc held 1,907 shares of Amgen worth $691K as of Q2 2026.
  • Blue Trust Inc sold 140 Amgen shares in Q2 2026, an estimated $47.9K.
  • Amgen made up 0.01% of Blue Trust Inc's portfolio in Q2 2026, its #384 holding.
  • Blue Trust Inc first reported a position in Amgen in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Amgen position peaked at $1.15M in Q3 2024.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.